Cargando…
Incidence and gravity of COVID-19 in patients with allergic rhinitis under treatment with sublingual immunotherapy
Autores principales: | De Oliveira Santos, Júlia Gaspar, Rimoli, Caroline Fernandes, Sparaga, Lucas Demetrio, Dedavid, Vittoria Senna, Oyama, Letícia Akazaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Editora Ltda.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582984/ http://dx.doi.org/10.1016/j.bjorl.2022.10.003 |
Ejemplares similares
-
Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011) -
Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
por: Aboshady, Omar Ali, et al.
Publicado: (2014) -
Effect of sublingual immunotherapy on platelet activity in children with allergic rhinitis()
por: Chen, Yanqiu, et al.
Publicado: (2016) -
Nasal microbes in allergic rhinitis children with or without sublingual immunotherapy
por: Shen, Xiao-Fei, et al.
Publicado: (2023) -
Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
por: Zeng, Yinhui, et al.
Publicado: (2023)